Ftse Mib
36.581,48
-0,38%
DAX
21.585,93
0,35%
S&P 500
6.061,48
0,39%
NASDAQ
19.692,33
0,19%
Bitcoin
96.668,63
0,05%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Enveric Biosciences Inc (ENVB) Enveric Biosciences Inc (ENVB) Notizie

Enveric Biosciences Inc

ENVB
1,65
-0,09 (-5,17%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 01:07:15
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/2/202523:15EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
05/2/202501:51EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
04/2/202514:00BWEnveric Biosciences and Restoration Biologics Announce..
03/2/202523:30EDGAR2Form 8-K - Current report
03/2/202523:00BWEnveric Biosciences Announces Closing of $5 Million Public..
03/2/202512:24EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
31/1/202502:14BWEnveric Biosciences Announces Pricing of $5 Million Public..
30/1/202523:10EDGAR2Form S-1/A - General form for registration of securities..
30/1/202522:01BWEnveric Biosciences Receives Notice of Allowance for Lead..
30/1/202514:01EDGAR2Form S-1/A - General form for registration of securities..
27/1/202512:10EDGAR2Form 8-K/A - Current report: [Amend]
21/1/202523:10EDGAR2Form 8-K - Current report
14/1/202523:09EDGAR2Form S-1 - General form for registration of securities under..
06/1/202515:10BWEnveric Biosciences to Present at and Participate in Panel..
06/1/202514:30BWEnveric Biosciences to Present at and Participate in Panel..
18/12/202414:30EDGAR2Form DEF 14A - Other definitive proxy statements
12/12/202418:04EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
02/12/202414:00BWEnveric Biosciences Announces New U.S. Patents Supporting..
27/11/202422:36EDGAR2Form PRE 14A - Other preliminary proxy statements
25/11/202415:00BWEnveric Biosciences Preclinical Pharmacokinetic Studies of..
22/11/202422:45EDGAR2Form 8-K - Current report
14/11/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202422:05EDGAR2Form 8-K - Current report
14/11/202422:05BWEnveric Biosciences Reports Third Quarter 2024 Financial and..
13/11/202417:18EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202419:43EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202415:00BWEnveric Biosciences Signs Out-Licensing Agreement with..
04/11/202416:36BWEnveric Biosciences Announces Broad Range of Patent..
15/10/202414:00BWEnveric Biosciences Announces Positive Pharmacology and..
12/10/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202401:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202401:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202401:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202401:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202401:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202414:30BWEnveric Biosciences Presents Data Highlighting Development..
25/9/202414:30BWEnveric Biosciences Presents Data on Lead Product Candidate,..
12/9/202415:35EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/9/202400:43EDGAR2Form S-1 - General form for registration of securities under..
04/9/202414:00BWEnveric Biosciences to Present at the H.C. Wainwright 26th..
22/8/202414:00EDGAR2Form 8-K - Current report
13/8/202414:00BWAries Science & Technology and Enveric Biosciences Announce..
12/8/202423:30BWEnveric Biosciences Reports Second Quarter 2024 Financial..
12/8/202423:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202423:05EDGAR2Form 8-K - Current report
25/7/202414:00BWEnveric Biosciences Announces Preclinical Results Confirming..
15/7/202415:02BWAries Science & Technology and Enveric Biosciences Announce..
15/7/202414:00EDGAR2Form 8-K - Current report
Apertura: 1,72 Min: 1,67 Max: 1,7899
Chiusura: 1,74

La tua Cronologia

NASDAQ
ENVB
Enveric Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci